Today: 22 January 2026
Subscribe
Browse Category

Stocks News 13 November 2025 - 18 November 2025

Broadcom’s $10B AI Deal Sparks 90% Rally – What’s Next for AVGO Stock?

Broadcom (AVGO) Stock on November 18, 2025: Price Action, NEC Cloud Deal, Fidelity Lawsuit and What It All Means for Investors

New York – November 18, 2025 — Broadcom Inc. (NASDAQ: AVGO) is back in the spotlight today as its share price comes under pressure alongside a broader tech sell-off, even while fresh news on cloud partnerships and lingering legal risk keep the story very active. As of this afternoon, Broadcom stock is trading around $337 per share, down roughly 1.5% on the day,…
18 November 2025
···
Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms

HIMS Stock Today (November 18, 2025): Buyback, GLP‑1 Price War and What It Means for Hims & Hers Investors

On Tuesday, November 18, 2025, Hims & Hers Health (NYSE: HIMS) is trading in the shadow of a sharp sell‑off, a fresh $250 million share repurchase authorization, and escalating price competition in the weight‑loss drug market. Together, these forces are shaping how traders and long‑term investors are thinking about HIMS stock today. HIMS stock price snapshot for November 18, 2025…
18 November 2025
·
Coinbase (COIN) Slides as Texas Move, Stablecoin Rewards Fight and New Product Launches Collide – November 14, 2025

Coinbase (COIN) Stock Today, November 18, 2025: Bitcoin Below $90,000 and Wall Street’s Latest Calls

Published: November 18, 2025 – This article is informational only and not investment advice. Coinbase Global, Inc. (NASDAQ: COIN) is back in the spotlight today as a sharp crypto sell-off drags Bitcoin below $90,000 and sends shockwaves through crypto‑linked stocks. At the same time, Wall Street analysts are updating their price targets, institutions are tweaking positions, and on‑chain data is…
18 November 2025
····
Applied Therapeutics (APLT) Stock Explodes on Heavy Volume as FDA Scrutiny and Cash Concerns Collide – November 17, 2025

Applied Therapeutics (APLT) Stock Explodes on Heavy Volume as FDA Scrutiny and Cash Concerns Collide – November 17, 2025

Applied Therapeutics Inc. (NASDAQ: APLT) is back on traders’ radar today, with its penny stock surging on enormous volume despite intense regulatory uncertainty and a stretched balance sheet. On November 17, 2025, APLT is trading like a biotech rollercoaster: pre‑market gains, intraday spikes of 30–70%, and tens of millions of shares changing hands as investors reassess the company’s prospects after…
17 November 2025
···
Alibaba (BABA) Stock Today, Nov. 17, 2025: Shares Rebound on Qwen AI App Launch as Washington Scrutiny Intensifies

Alibaba (BABA) Stock Today, Nov. 17, 2025: Shares Rebound on Qwen AI App Launch as Washington Scrutiny Intensifies

Dateline — Monday, November 17, 2025. Alibaba’s U.S.–listed shares were higher at mid‑day after the company pushed deeper into consumer AI with a public beta of its new Qwen app, even as political pressure in Washington escalated following last week’s allegation that Alibaba aids China’s military—an allegation the company denies. Key takeaways Market snapshot: BABA on Monday BABA changed hands…
17 November 2025
···
Elbit Systems (ESLT) Jumps on $2.3 Billion Contract Win as Q3 Earnings Loom – 17 November 2025 Update

Elbit Systems (ESLT) Jumps on $2.3 Billion Contract Win as Q3 Earnings Loom – 17 November 2025 Update

Elbit Systems Ltd. (NASDAQ: ESLT; TASE: ESLT) is back in the global spotlight today after announcing a massive $2.3 billion international defense contract, sending the stock sharply higher just one day before its third‑quarter 2025 earnings report. The deal, disclosed via a company press release that was also filed with the U.S. Securities and Exchange Commission on Form 6‑K, covers…
17 November 2025
···
Pfizer (PFE) Clinches $10B Metsera Deal, Beating Novo Nordisk — What the Winning Bid Means for the Obesity-Drug Race (Nov. 8, 2025)

Pfizer (PFE) Stock: 9 Things to Know Before the Market Opens on November 17, 2025

New York — As U.S. markets get ready to reopen on Monday, November 17, 2025, Pfizer (NYSE: PFE) heads into the week at a critical turning point: COVID cash flows are fading, an obesity-drug arms race is heating up, a major activist has just walked away, and management is betting billions on a new growth story. Here’s a concise but…
16 November 2025
····
Archer Aviation (ACHR) Raises $650M, Moves to Buy Hawthorne Airport for $126M; Shares Slip After Q3 Update — Nov. 7, 2025

Archer Aviation (ACHR) Stock Today — Nov 15, 2025: $650M Share Sale, Los Angeles Airport Deal, UAE Flight Tests & What They Mean for 2026

Updated: November 15, 2025 Key takeaways What changed for ACHR in November 1) A bigger cash war chest—at a cost.On Nov. 6, Archer disclosed a $650M equity raise, executed as a registered direct sale of 81.25M shares priced at $8.00. The company’s own filings show 651.3M Class A shares outstanding at Sept. 30; the new issuance implies roughly 12.5% incremental…
15 November 2025
····
Quantum Stocks Rip Higher: IonQ Up 700% – Bubble or Breakthrough?

IonQ (IONQ) Stock Today, Nov 15, 2025: Q3 Beat, DARPA Stage‑B Win, UChicago Pact—What It Means for 2026

Updated: November 15, 2025 TL;DR — IonQ closed $47.18 on Friday, Nov 14 (52‑week $17.88–$84.64). November brought a trio of material catalysts: a Q3 revenue beat with guidance raised, selection to DARPA’s Quantum Benchmarking Initiative (Stage B), and a landmark University of Chicago partnership that will place a production‑grade quantum system and an entanglement network on campus. With pro‑forma cash…
15 November 2025
···
Invivyd (IVVD) Rockets Over 50% Pre‑Market on November 14, 2025 as Traders Rush Into COVID Antibody Play

Invivyd (IVVD) Rockets Over 50% Pre‑Market on November 14, 2025 as Traders Rush Into COVID Antibody Play

Invivyd, Inc. (NASDAQ: IVVD) is back in the spotlight this Friday, November 14, 2025, with its stock exploding higher in pre‑market trading on the back of building momentum around its COVID‑19 antibody franchise and recent earnings. By early morning, IVVD was one of the most actively watched biotech names on Wall Street. Invivyd stock today: IVVD among top pre‑market gainers…
14 November 2025
··
Northland Power (TSX:NPI) Stock Plunges as Q3 2025 Revenue Beat is Overshadowed by 40% Dividend Cut and Hai Long Delay

Northland Power (TSX:NPI) Stock Plunges as Q3 2025 Revenue Beat is Overshadowed by 40% Dividend Cut and Hai Long Delay

Northland Power Inc. (TSX: NPI, NPI.TO) is under heavy pressure today after reporting third‑quarter 2025 results, cutting its dividend by 40% and warning that delays at its flagship Hai Long offshore wind project could hit 2026 revenues. The stock is trading around C$19 today, down more than 20% from Wednesday’s close near C$25, according to intraday quote data. StockInvest Key…
13 November 2025
····
Ondas Holdings (ONDS) Stock Skyrockets 770% – Huge Deals, Price Swings & 2025 Outlook

Ondas Holdings Stock (ONDS) Today, November 13, 2025: Q3 Earnings on Deck After a Volatile, High-Growth Year

Ondas Holdings (NASDAQ: ONDS) heads into Thursday, November 13, 2025 as one of the most closely watched small-cap defense-tech names on the market. The company is scheduled to report third‑quarter 2025 results and host its earnings call before the U.S. market opens, a catalyst that could inject fresh volatility into a stock that has already surged several hundred percent over…
13 November 2025
···
1 … 70 71 72 73 74 … 89

Stock Market Today

  • New Price Target Sparks Fresh Analysis on Hiscox (LSE:HSX) Shares
    January 21, 2026, 10:53 PM EST. Hiscox (LSE:HSX) recently received a new analyst price target, reshaping investor perspectives on the insurer's valuation. This benchmark provides a reference point amid varied risks such as underwriting discipline and exposure to large claims events. The updated target encourages shareholders to reassess earnings quality, capital strength, and fair value assumptions. Investors are advised to consider this price target as part of a broader valuation range, not a precise forecast, due to differing opinions on Hiscox's future prospects. Simply Wall St's platform offers tools for tracking narrative changes, comparing analyst views, and adjusting investment strategies based on evolving market data and forecasts.
Go toTop